Prostate Cancer and Prostatic Diseases

Prostate Cancer and Prostatic Diseases 由 Springer Nature 出版，属中科院医学大类（2025 升级版2区）。按 OpenAlex 近年发文统计，该刊主要发表 Prostate Cancer Diagnosis and Treatment、Prostate Cancer Treatment and Research、Urinary Bladder and Prostate Research 等主题的论文，这 3 个主题约占 65.8%。（根据 OpenAlex 主题统计与中科院分区数据生成）

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance. The following is a non-exhaustive list of the general topics covered by Prostate Cancer and Prostatic Diseases: Alternative therapies Angiogenesis Anti-sense oligonucleotides against growth factors Brachytherapy Conformal radiotherapy Conformal radiotherapy Cyclotron fast neutron treatment Enhancing the results of radical prostatectomy Epidemiology of prostate cancer and prostatic diseases Familial prostate cancer Free to total PSA Gene therapy for prostate cancer Genetic basis for prostate cancer Hormone-related disease How significant is PSA-detected disease? Intermittent antiandrogen therapy Mechanisms of tumour invasion in prostate cancer Medical and surgical therapies for male LUTS Medical therapy for male LUTS: the road ahead Natural history of prostate cancer and prostatic diseases Nutrition in prostate cancer and prostatic diseases Photodynamic therapy Prognostic markers Prostate cancer and potency and impotence Prostatic intra-epithelial neoplasia - an important precursor of cancer Prostatitis: quo vadis? Quality of life issues Racial issues in prostate cancer Recurrence after radical prostatectomy Reproducibility (test-retest reliability) of investigations for prostatic diseases Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA Role of differentiation therapy Screening for prostate cancer Staging of prostate cancer: beyond conventional imaging The ma

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-泌尿学与肾脏学

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

MEDLINEEmbaseCurrent Contents出版商官网

其他：Index Medicus

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

6.74LetPub · 2026-09-13

影响因子（出版商公布） 2025

6.9出版商官网 · 2026-09-29

五年影响因子（出版商公布） 2025

5.6出版商官网 · 2026-09-29

CiteScore 2026-06

11.9LetPub · 2026-09-13

SJR 2026-06

2.03LetPub · 2026-09-13

SNIP 2026-06

1.82LetPub · 2026-09-13

h-index

56LetPub · 2026-09-13

h-index

100OpenAlex · 2026-10-01

i10-index

1,505OpenAlex · 2026-10-01

两年平均被引

5.8OpenAlex · 2026-10-01

自引率

11.6%LetPub · 2026-09-13

Gold OA 文章占比

34.08%LetPub · 2026-09-13

发文规模

年文章数

95LetPub · 2026-09-13

年下载量（出版商公布） 2025

1,374,753出版商官网 · 2026-09-29

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

较慢,6-12周LetPub · 2026-09-13

平均录用比例（社区反馈）

较易LetPub · 2026-09-13

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Springer Nature

出版国家或地区

ENGLAND

出版语言

English

出版周期

Quarterly

创刊年份

1997

ISSN

1365-7852

电子版 ISSN

1476-5608

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗LetPub
• 作者指南 ↗LetPub
• 专刊 / 特刊征稿 ↗出版商官网